Cristina Agustí
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Cristina Agustí has a total of 240 co-authors. Here are the top co-authors by number of shared publications:
Jordi Casabona
Department of Genetics and Microbiology, Autonomous University of Barcelona, Badalona, Spain
17 shared publications- Jordi Casabona
Centre Estudis Epidemiològics Sobre les Infeccions de Transmissió Sexual i Sida de Catalunya (CEEISCAT), Department de Salut, Generalitat de Catalunya, 08916 Badalona, Spain
8 shared publications - Héctor Martínez-Riveros
Doctorate Program in Methodology of Biomedical Research and Public Health, Department of Paediatrics, Obstetrics and Gynaecology and Preventive Medicine, Universitat Autònoma de Barcelona, Badalona, Spain
6 shared publications Yesika Díaz
Centre of Epidemiological Studies of HIV/AIDS and STI of Catalonia (CEEISCAT), Health Department, Generalitat de Catalunya, Badalona, Barcelona, Spain
6 shared publications- Juan Hoyos
Independent Researcher, Madrid, Spain
5 shared publications Juanjo Mascort
Department of Clinical Sciences, Faculty of Medicine, University of Barcelona, Barcelona, Spain
5 shared publications
Latest Publications
- 22 October 2026
- Published by Wiley in HIV Medicine
Sex‐ and migration‐related differences in viral suppression and life expectancy among people with HIV : The PISCIS cohort, 1998–2023
Background: Despite advances in antiretroviral therapy (ART), inequalities in HIV outcomes persist by sex and migration status. Few studies have examined how these factors jointly relate to treatment outcomes across successive ART eras. Aim: To examine differences in time to first viral suppression and life expectancy according to sex and migration status, and how these differences changed across successive ART eras. Methods: We conducted a population‐based retrospective cohort study using the PISCIS cohort in Catalonia and the Balearic Islands, Spain. Participants aged ≥16 years diagnosed with HIV between 1998 and 2023, with a recorded ART initiation date and at least one viral load measurement within 12 months after ART initiation, were included. Time to first viral suppression (p < 0.001): Migrant women had a lower adjusted hazard of viral suppression than migrant MSM (aHR 0.77, 95% CI 0.67–0.89), while a particularly low hazard was observed among migrant heterosexual men (aHR 0.60, 95% CI 0.51–0.69). Life expectancy at age 20 increased by approximately 12 years across all groups over the study period, with differences between groups narrowing over time. Conclusion: Viral suppression and life expectancy improved substantially across all sex‐migration groups over 26 years. However, differences in time to viral suppression persisted in the most recent ART era, including slower suppression among migrant women compared with migrant men. Further disaggregation of sexually acquired HIV revealed additional heterogeneity, particularly between migrant MSM and heterosexual men. These findings highlight the importance of considering the intersection of sex, migration status and HIV acquisition group to better identify population‐specific inequalities in HIV care.
- 22 October 2026
- Published by Wiley in HIV Medicine
Sex‐ and migration‐related differences in viral suppression and life expectancy among people with HIV : The PISCIS cohort, 1998–2023
Background: Despite advances in antiretroviral therapy (ART), inequalities in HIV outcomes persist by sex and migration status. Few studies have examined how these factors jointly relate to treatment outcomes across successive ART eras. Aim: To examine differences in time to first viral suppression and life expectancy according to sex and migration status, and how these differences changed across successive ART eras. Methods: We conducted a population‐based retrospective cohort study using the PISCIS cohort in Catalonia and the Balearic Islands, Spain. Participants aged ≥16 years diagnosed with HIV between 1998 and 2023, with a recorded ART initiation date and at least one viral load measurement within 12 months after ART initiation, were included. Time to first viral suppression (p < 0.001): Migrant women had a lower adjusted hazard of viral suppression than migrant MSM (aHR 0.77, 95% CI 0.67–0.89), while a particularly low hazard was observed among migrant heterosexual men (aHR 0.60, 95% CI 0.51–0.69). Life expectancy at age 20 increased by approximately 12 years across all groups over the study period, with differences between groups narrowing over time. Conclusion: Viral suppression and life expectancy improved substantially across all sex‐migration groups over 26 years. However, differences in time to viral suppression persisted in the most recent ART era, including slower suppression among migrant women compared with migrant men. Further disaggregation of sexually acquired HIV revealed additional heterogeneity, particularly between migrant MSM and heterosexual men. These findings highlight the importance of considering the intersection of sex, migration status and HIV acquisition group to better identify population‐specific inequalities in HIV care.
- Open Access
- 8 April 2026
- Published by Wiley in Journal of Medical Virology
- Vol. 98 (4) , e70908
Concordance and Acceptability of Self‐ Vs. Clinician‐Collected Anorectal Swabs for HPV Genotyping in Gay, Bisexual and Other Men Who Have Sex With Men in Metropolitan Barcelona
Squamous cell carcinoma of the anus (SCCA), caused by high‐risk human papillomavirus (HR‐HPV) genotypes, is a growing concern among gay, bisexual, and other men who have sex with men and transgender individuals, particularly those living with HIV. Early detection of precursor lesions is crucial, yet current screening methods face barriers in access and acceptability. Anal self‐sampling has emerged as a promising patient‐centered alternative. This study evaluates the diagnostic accuracy and feasibility of self‐collected anal swabs for HPV genotyping compared to clinician‐collected swabs among the target population. A cross‐sectional, multicenter study was conducted in the metropolitan area of Barcelona, enrolling 151 participants. Participants provided self‐ and clinician‐collected anal samples, obtained sequentially. Extended genotyping was performed to detect 28 individual HPV genotypes. Diagnostic performance was evaluated using clinician‐collected samples as the reference standard, and concordance was assessed using McNemar's test and Cohen's κ statistic. Feasibility was measured via a questionnaire. Participants had a median age of 43 years, and 53.0% were living with HIV. Overall, HPV was detected in 89.9% of self‐ and 92.6% of clinician‐collected samples. Agreement was high 96.0%, with a κ value of 0.75 (95% CI: 0.55–0.94). No significant differences were found between methods ( p = 0.22). Sensitivity was 96.4% (95% CI: 91.8–98.4), and specificity 90.9% (95% CI: 62.3–98.4), with similar accuracy for HR‐HPV and HPV16 types. Most participants rated self‐sampling acceptable and feasible. Anal self‐sampling shows high accuracy and strong feasibility, supporting its use as a viable and user‐friendly strategy to enhance HPV screening in key populations at risk for SCCA.
- 8 April 2026
- Published by Wiley in Journal of Medical Virology
- Vol. 98 (4) , e70908
Open AccessConcordance and Acceptability of Self‐ Vs. Clinician‐Collected Anorectal Swabs for HPV Genotyping in Gay, Bisexual and Other Men Who Have Sex With Men in Metropolitan Barcelona
Squamous cell carcinoma of the anus (SCCA), caused by high‐risk human papillomavirus (HR‐HPV) genotypes, is a growing concern among gay, bisexual, and other men who have sex with men and transgender individuals, particularly those living with HIV. Early detection of precursor lesions is crucial, yet current screening methods face barriers in access and acceptability. Anal self‐sampling has emerged as a promising patient‐centered alternative. This study evaluates the diagnostic accuracy and feasibility of self‐collected anal swabs for HPV genotyping compared to clinician‐collected swabs among the target population. A cross‐sectional, multicenter study was conducted in the metropolitan area of Barcelona, enrolling 151 participants. Participants provided self‐ and clinician‐collected anal samples, obtained sequentially. Extended genotyping was performed to detect 28 individual HPV genotypes. Diagnostic performance was evaluated using clinician‐collected samples as the reference standard, and concordance was assessed using McNemar's test and Cohen's κ statistic. Feasibility was measured via a questionnaire. Participants had a median age of 43 years, and 53.0% were living with HIV. Overall, HPV was detected in 89.9% of self‐ and 92.6% of clinician‐collected samples. Agreement was high 96.0%, with a κ value of 0.75 (95% CI: 0.55–0.94). No significant differences were found between methods ( p = 0.22). Sensitivity was 96.4% (95% CI: 91.8–98.4), and specificity 90.9% (95% CI: 62.3–98.4), with similar accuracy for HR‐HPV and HPV16 types. Most participants rated self‐sampling acceptable and feasible. Anal self‐sampling shows high accuracy and strong feasibility, supporting its use as a viable and user‐friendly strategy to enhance HPV screening in key populations at risk for SCCA.
- Open Access
Usefulness of Dried Blood Spot Samples for Syphilis Screening
Dried blood spots (DBSs) are a practical tool for diagnosing infectious diseases, especially in remote or resource-limited settings. This study assessed the efficacy of DBS-based serological assays for syphilis screening. EDTA blood samples from 171 syphilis-seropositive and 122 seronegative individuals were used to prepare DBSs by spotting whole blood onto filter paper. After drying, 12 mm disks were punched, incubated overnight in buffered solution, and centrifuged. Syphilis serological screening was conducted using the Liaison® Treponema Screen assay, Macro-Vue™ Reagin Plasma Rapid (RPR) card test, and Dual Path Platform (DPP) Syphilis Screen and Confirm test. The Liaison® assay demonstrated 100% sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) with an optimized cut-off. The nontreponemal RPR test showed very low sensitivity (2.9%) on DBS but perfect specificity (100%). The DPP test for treponemal antibodies achieved high sensitivity (92.1%) and specificity (98.2%) with microreader adjustment. Visual reading of the DPP test had variable accuracy, with sensitivity reaching 100% but lower specificity (42.1%). Nontreponemal antibody detection by DPP showed moderate sensitivity and specificity. Although nontreponemal testing requires refinement, DBS testing combined with point-of-care tests like DPP holds promise for expanding syphilis screening accessibility and decentralization globally, particularly in resource-constrained environments.
Open AccessUsefulness of Dried Blood Spot Samples for Syphilis Screening
Dried blood spots (DBSs) are a practical tool for diagnosing infectious diseases, especially in remote or resource-limited settings. This study assessed the efficacy of DBS-based serological assays for syphilis screening. EDTA blood samples from 171 syphilis-seropositive and 122 seronegative individuals were used to prepare DBSs by spotting whole blood onto filter paper. After drying, 12 mm disks were punched, incubated overnight in buffered solution, and centrifuged. Syphilis serological screening was conducted using the Liaison® Treponema Screen assay, Macro-Vue™ Reagin Plasma Rapid (RPR) card test, and Dual Path Platform (DPP) Syphilis Screen and Confirm test. The Liaison® assay demonstrated 100% sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) with an optimized cut-off. The nontreponemal RPR test showed very low sensitivity (2.9%) on DBS but perfect specificity (100%). The DPP test for treponemal antibodies achieved high sensitivity (92.1%) and specificity (98.2%) with microreader adjustment. Visual reading of the DPP test had variable accuracy, with sensitivity reaching 100% but lower specificity (42.1%). Nontreponemal antibody detection by DPP showed moderate sensitivity and specificity. Although nontreponemal testing requires refinement, DBS testing combined with point-of-care tests like DPP holds promise for expanding syphilis screening accessibility and decentralization globally, particularly in resource-constrained environments.
- Open Access
- 19 June 2025
- Published by European Centre for Disease Control and Prevention (ECDC) in Eurosurveillance
- Vol. 30 (24) , 2400585
Implicit bias in HIV testing based on indicator conditions in primary care: a population-based study in Catalonia, Spain, 2017 to 2021
BACKGROUND: HIV testing guided by indicator condition (IC) is recommended by the World Health Organization to facilitate earlier diagnosis. However, it is unclear to what extent these guidelines are followed in routine primary care (PC). AIM: To estimate the prevalence and distribution of ICs in PC in Catalonia, Spain, identify factors associated with, and prevalence of, an HIV test being administered, or not, within 4 months of IC diagnosis and assess trends over time. METHODS: A population-based cross-sectional study was conducted using data from the Information System for the Development of Research in Primary Care, covering 5.8 million individuals in Catalonia. We identified IC episodes recorded from 1 January 2017 to 31 August 2021 among patients aged 16–65 years. For each IC episode, we assessed whether an HIV test was performed within 4 months. RESULTS: We identified 372,712 IC episodes; 84,694 (22.7%) led to an HIV test within 4 months. Testing was higher for: men (26.3% vs 19.4% for women); migrants (27.7% vs 21.3% for Spanish citizens); younger patients (29.2% for 16–30-year-olds vs 13.7% for those over 50 years). Testing rates were highest for episodes involving syphilis (68.4%), genital herpes (50.6%), chlamydia (48.2%) and gonorrhoea (43.1%). Factors associated with increased testing included male sex, higher socioeconomic deprivation area, presence of an acute sexually transmitted infection and multiple ICs. CONCLUSION: Substantial gaps remain in HIV testing based on ICs in PC in Catalonia. Targeted interventions are needed to improve adherence to IC-guided testing, enabling early HIV diagnosis and treatment.
- 19 June 2025
- Published by European Centre for Disease Control and Prevention (ECDC) in Eurosurveillance
- Vol. 30 (24) , 2400585
Open AccessImplicit bias in HIV testing based on indicator conditions in primary care: a population-based study in Catalonia, Spain, 2017 to 2021
BACKGROUND: HIV testing guided by indicator condition (IC) is recommended by the World Health Organization to facilitate earlier diagnosis. However, it is unclear to what extent these guidelines are followed in routine primary care (PC). AIM: To estimate the prevalence and distribution of ICs in PC in Catalonia, Spain, identify factors associated with, and prevalence of, an HIV test being administered, or not, within 4 months of IC diagnosis and assess trends over time. METHODS: A population-based cross-sectional study was conducted using data from the Information System for the Development of Research in Primary Care, covering 5.8 million individuals in Catalonia. We identified IC episodes recorded from 1 January 2017 to 31 August 2021 among patients aged 16–65 years. For each IC episode, we assessed whether an HIV test was performed within 4 months. RESULTS: We identified 372,712 IC episodes; 84,694 (22.7%) led to an HIV test within 4 months. Testing was higher for: men (26.3% vs 19.4% for women); migrants (27.7% vs 21.3% for Spanish citizens); younger patients (29.2% for 16–30-year-olds vs 13.7% for those over 50 years). Testing rates were highest for episodes involving syphilis (68.4%), genital herpes (50.6%), chlamydia (48.2%) and gonorrhoea (43.1%). Factors associated with increased testing included male sex, higher socioeconomic deprivation area, presence of an acute sexually transmitted infection and multiple ICs. CONCLUSION: Substantial gaps remain in HIV testing based on ICs in PC in Catalonia. Targeted interventions are needed to improve adherence to IC-guided testing, enabling early HIV diagnosis and treatment.
- 25 February 2025
- Published by BMJ in Sexually Transmitted Infections
- Vol. 101 (8) , 529-533
TESTATE STI project: an online chlamydia and gonorrhoea self-sampling strategy for gay, bisexual and other men who have sex with men and trans people in Catalonia (Spain)
Objectives: TESTATE STI is an online offer of self-sampling kits (SSKs) for the detection of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) among gay, bisexual and other men who have sex with men (GBMSM) and transgender people (TG) in Catalonia. The aims of this study are: 1) to develop and evaluate the effectiveness, satisfaction and willingness of a pilot online intervention that includes the offer of SSKs for CT/NG screening with online consultation of subsequent results and (2) to analyse its potential as an effective strategy to encourage diagnosis, linkage to treatment and to describe contact notification by participants with a positive diagnosis. Methods: The distribution of SSKs, which included a urine collection tube, a pharyngeal and a rectal swab, was conducted through two recruitment strategies: autonomously via social media and GBMSM or TG leisure spaces, or accompanied by community-based organisations. Participants completed a socio-demographic, biobehavioural and satisfaction survey. Results: A total of 386 kits were tested in the laboratory. The estimated positivity rate for having at least one STI was 20.7%. TESTATE STI indicates that approximately 90.0% of positive participants were extragenital. 81.0% of positive cases were linked to the health system, and 96.9% of those were treated. We estimate that five kits must be performed to detect a positive CT/NG with the TESTATE STI intervention. Almost all participants (98.8%) would recommend taking the chlamydia and gonorrhoea self-sampling with TESTATE STI. Conclusion: The TESTATE STI project concluded that the deployment of SSKs for the detection of CT/NG is a viable and feasible strategy for GBMSM and TG in Catalonia. TESTATE STI is an effective strategy for encouraging diagnosis, treatment linkage and contact notification. Implementing TESTATE STI would increase access to confidential testing and promote early STI detection.
- 25 February 2025
- Published by BMJ in Sexually Transmitted Infections
- Vol. 101 (8) , 529-533
TESTATE STI project: an online chlamydia and gonorrhoea self-sampling strategy for gay, bisexual and other men who have sex with men and trans people in Catalonia (Spain)
Objectives: TESTATE STI is an online offer of self-sampling kits (SSKs) for the detection of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) among gay, bisexual and other men who have sex with men (GBMSM) and transgender people (TG) in Catalonia. The aims of this study are: 1) to develop and evaluate the effectiveness, satisfaction and willingness of a pilot online intervention that includes the offer of SSKs for CT/NG screening with online consultation of subsequent results and (2) to analyse its potential as an effective strategy to encourage diagnosis, linkage to treatment and to describe contact notification by participants with a positive diagnosis. Methods: The distribution of SSKs, which included a urine collection tube, a pharyngeal and a rectal swab, was conducted through two recruitment strategies: autonomously via social media and GBMSM or TG leisure spaces, or accompanied by community-based organisations. Participants completed a socio-demographic, biobehavioural and satisfaction survey. Results: A total of 386 kits were tested in the laboratory. The estimated positivity rate for having at least one STI was 20.7%. TESTATE STI indicates that approximately 90.0% of positive participants were extragenital. 81.0% of positive cases were linked to the health system, and 96.9% of those were treated. We estimate that five kits must be performed to detect a positive CT/NG with the TESTATE STI intervention. Almost all participants (98.8%) would recommend taking the chlamydia and gonorrhoea self-sampling with TESTATE STI. Conclusion: The TESTATE STI project concluded that the deployment of SSKs for the detection of CT/NG is a viable and feasible strategy for GBMSM and TG in Catalonia. TESTATE STI is an effective strategy for encouraging diagnosis, treatment linkage and contact notification. Implementing TESTATE STI would increase access to confidential testing and promote early STI detection.
- Open Access
- 8 February 2024
- Published by Elsevier in Atencion Primaria
- Vol. 56 (5)
El rompecabezas de las ITS: causas plurales, impacto profundo
- 8 February 2024
- Published by Elsevier in Atencion Primaria
- Vol. 56 (5)
Open AccessEl rompecabezas de las ITS: causas plurales, impacto profundo
- Open Access
- 5 January 2024
- Published by Frontiers Media SA in Frontiers in Pediatrics
- Vol. 11, 1353806
Corrigendum: Feasibility of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigen self-testing in school and summer camp attendees
Corrigendum: Feasibility of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigen self-testing in school and summer camp attendees
- 5 January 2024
- Published by Frontiers Media SA in Frontiers in Pediatrics
- Vol. 11, 1353806
Open AccessCorrigendum: Feasibility of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigen self-testing in school and summer camp attendees
Corrigendum: Feasibility of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigen self-testing in school and summer camp attendees
- Open Access
Feasibility and impact of online HIV/STI screening addressed to men who have sex with men and transgender women users of pre-exposure prophylaxis (PrEP) in Spain (TESTATE PrEP): a study protocol for a non-blinded randomised controlled trial
Introduction: The objectives of the study are: to design and implement a pilot intervention to offer self-sampling kits to detect HIV, Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG) and Treponema pallidum (TP) among gay, bisexual and other men who have sex with men and transgender women users of pre-exposure prophylaxis (PrEP) as part of PrEP follow-up. To evaluate if the pilot intervention causes a reduction of the retention to PrEP follow-up among the target population. To analyse the capacity of the intervention to reduce the healthcare burden on the PrEP service. To evaluate the acceptability of the intervention among PrEP users and PrEP service healthcare workers and; to validate dried blood samples for treponemal and non-treponemal antibody detection using the Dual Path Platform syphilis screening and confirmatory assay compared with blood drawn by venous puncture. Methods and analysis: We will perform a non-blinded randomised controlled non-inferiority trial among PrEP users on follow-up. Participants on the control arm will follow the usual follow-up protocol with quarterly face-to-face visits where they will be tested for HIV and sexually transmitted infections (STIs). Participants in the experimental arm will alternate face-to-face meetings with online screening of HIV and STIs. The website https://testate.org/ will include a module for online follow-up visits of participants. Participants of the experimental arm will order self-sampling kits for HIV, CT, NG and TP through the website, will send the samples to the laboratory and check their results online. We will compare the retention to follow up and the healthcare burden in both arms. The acceptability of the intervention among participants and healthcare workers will be assessed. Ethics and dissemination: The project has been approved by the CEIC-HUGTIP (Reference: PI-22-051). Subjects will be included after giving their informed consent. Final conclusions and recommendations will be shared with stakeholders. Two publications in peer-reviewed journals are expected. Trial registration number: NCT05752643 .
Open AccessFeasibility and impact of online HIV/STI screening addressed to men who have sex with men and transgender women users of pre-exposure prophylaxis (PrEP) in Spain (TESTATE PrEP): a study protocol for a non-blinded randomised controlled trial
Introduction: The objectives of the study are: to design and implement a pilot intervention to offer self-sampling kits to detect HIV, Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG) and Treponema pallidum (TP) among gay, bisexual and other men who have sex with men and transgender women users of pre-exposure prophylaxis (PrEP) as part of PrEP follow-up. To evaluate if the pilot intervention causes a reduction of the retention to PrEP follow-up among the target population. To analyse the capacity of the intervention to reduce the healthcare burden on the PrEP service. To evaluate the acceptability of the intervention among PrEP users and PrEP service healthcare workers and; to validate dried blood samples for treponemal and non-treponemal antibody detection using the Dual Path Platform syphilis screening and confirmatory assay compared with blood drawn by venous puncture. Methods and analysis: We will perform a non-blinded randomised controlled non-inferiority trial among PrEP users on follow-up. Participants on the control arm will follow the usual follow-up protocol with quarterly face-to-face visits where they will be tested for HIV and sexually transmitted infections (STIs). Participants in the experimental arm will alternate face-to-face meetings with online screening of HIV and STIs. The website https://testate.org/ will include a module for online follow-up visits of participants. Participants of the experimental arm will order self-sampling kits for HIV, CT, NG and TP through the website, will send the samples to the laboratory and check their results online. We will compare the retention to follow up and the healthcare burden in both arms. The acceptability of the intervention among participants and healthcare workers will be assessed. Ethics and dissemination: The project has been approved by the CEIC-HUGTIP (Reference: PI-22-051). Subjects will be included after giving their informed consent. Final conclusions and recommendations will be shared with stakeholders. Two publications in peer-reviewed journals are expected. Trial registration number: NCT05752643 .
- Open Access
- 2 October 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-11
Self-sampling monkeypox virus testing in high-risk populations, asymptomatic or with unrecognized Mpox, in Spain
The recent monkeypox virus (MPXV) outbreak was of global concern and has mainly affected gay, bisexual and other men who have sex with men (GBMSM). Here we assess prevalence of MPXV in high-risk populations of GBMSM, trans women (TW) and non-binary people without symptoms or with unrecognized monkeypox (Mpox) symptoms, using a self-sampling strategy. Anal and pharyngeal swabs are tested by MPXV real-time PCR and positive samples are tested for cytopathic effect (CPE) in cell culture. 113 individuals participated in the study, 89 (78.76%) were cis men, 17 (15.04%) were TW. The median age was 35.0 years (IQR: 30.0–43.0), 96 (85.02%) individuals were gay or bisexual and 72 (63.72%) were migrants. Seven participants were MPXV positive (6.19% (95% CI: 1.75%–10.64%)). Five tested positive in pharyngeal swabs, one in anal swab and one in both. Six did not present symptoms recognized as MPXV infection. Three samples were positive for CPE, and showed anti-vaccinia pAb staining by FACS and confocal microscopy. This suggests that unrecognized Mpox cases can shed infectious virus. Restricting testing to individuals reporting Mpox symptoms may not be sufficient to contain outbreaks.
- 2 October 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-11
Open AccessSelf-sampling monkeypox virus testing in high-risk populations, asymptomatic or with unrecognized Mpox, in Spain
The recent monkeypox virus (MPXV) outbreak was of global concern and has mainly affected gay, bisexual and other men who have sex with men (GBMSM). Here we assess prevalence of MPXV in high-risk populations of GBMSM, trans women (TW) and non-binary people without symptoms or with unrecognized monkeypox (Mpox) symptoms, using a self-sampling strategy. Anal and pharyngeal swabs are tested by MPXV real-time PCR and positive samples are tested for cytopathic effect (CPE) in cell culture. 113 individuals participated in the study, 89 (78.76%) were cis men, 17 (15.04%) were TW. The median age was 35.0 years (IQR: 30.0–43.0), 96 (85.02%) individuals were gay or bisexual and 72 (63.72%) were migrants. Seven participants were MPXV positive (6.19% (95% CI: 1.75%–10.64%)). Five tested positive in pharyngeal swabs, one in anal swab and one in both. Six did not present symptoms recognized as MPXV infection. Three samples were positive for CPE, and showed anti-vaccinia pAb staining by FACS and confocal microscopy. This suggests that unrecognized Mpox cases can shed infectious virus. Restricting testing to individuals reporting Mpox symptoms may not be sufficient to contain outbreaks.
- 13 September 2023
- Published by BMJ in Sexually Transmitted Infections
- Vol. 99 (8) , 541-547
Egocentric sexual network analysis among gay and bisexual men who have sex with men with and without mpox infection
Objectives: Recent outbreaks of the mpox (monkeypox) virus have been detected in dense sexual networks of gay and bisexual men who have sex with men (GBMSM). The objective of this study is to describe and compare the epidemiological and behavioural characteristics, as well as the sexual networks, of GBMSM diagnosed with mild mpox in Spain.Methods: A prospective case–control study was conducted in Spain from July 2022 to February 2023. The study targeted a key population of GBMSM aged 18 years or older. Study participants were categorised into cases, those who were diagnosed with mpox virus infection; and controls, those who were not diagnosed. We examined and compared the sexual network characteristics of the two groups—mpox-positive (mpox-P) and mpox-negative (mpox-N) egos—using χ2, t-test and Wilcoxon test to examine the differences between the two groups in each section. Finally, we conducted univariable and multivariable logistic regressions to determine the factors associated with mpox infection.Results: Among the 105 participants, 35 (33.3%) were mpox-P. Compared with mpox-N, mpox-P respondents more frequently reported syphilis (mpox-P: 31.4%; mpox-N: 12.9%) and HIV (mpox-P: 45.7%; mpox-N: 18.6%), and mpox-P individuals to have had at least one sexual contact with a confirmed mpox case (mpox-P: 62.5%; mpox-N: 8.3%). In the egocentric network analysis, mpox-P respondents had a higher prevalence of group sex with alters (mpox-P: 18.5%; mpox-N: 8.9%) and one-time sexual partners (mpox-P: 46.1%; mpox-N: 31.7%). Multivariable logistic regressions showed that reporting stranger/client ties (adjusted OR (aOR)=10.3, 95% CI 1.39 to 76.6) with alters, being vaccinated for mpox (aOR=0.07, 95% CI 0.02 to 0.24) and tie strength heterogeneity (aOR=0.01, 95% CI 0.00 to 0.42) were associated with mpox infection.Conclusions: Our findings highlight the role of demographic, epidemiological and sexual network characteristics in the transmission of mpox virus during the outbreak in Spain. These findings have important implications for future prevention efforts.
- 13 September 2023
- Published by BMJ in Sexually Transmitted Infections
- Vol. 99 (8) , 541-547
Egocentric sexual network analysis among gay and bisexual men who have sex with men with and without mpox infection
Objectives: Recent outbreaks of the mpox (monkeypox) virus have been detected in dense sexual networks of gay and bisexual men who have sex with men (GBMSM). The objective of this study is to describe and compare the epidemiological and behavioural characteristics, as well as the sexual networks, of GBMSM diagnosed with mild mpox in Spain.Methods: A prospective case–control study was conducted in Spain from July 2022 to February 2023. The study targeted a key population of GBMSM aged 18 years or older. Study participants were categorised into cases, those who were diagnosed with mpox virus infection; and controls, those who were not diagnosed. We examined and compared the sexual network characteristics of the two groups—mpox-positive (mpox-P) and mpox-negative (mpox-N) egos—using χ2, t-test and Wilcoxon test to examine the differences between the two groups in each section. Finally, we conducted univariable and multivariable logistic regressions to determine the factors associated with mpox infection.Results: Among the 105 participants, 35 (33.3%) were mpox-P. Compared with mpox-N, mpox-P respondents more frequently reported syphilis (mpox-P: 31.4%; mpox-N: 12.9%) and HIV (mpox-P: 45.7%; mpox-N: 18.6%), and mpox-P individuals to have had at least one sexual contact with a confirmed mpox case (mpox-P: 62.5%; mpox-N: 8.3%). In the egocentric network analysis, mpox-P respondents had a higher prevalence of group sex with alters (mpox-P: 18.5%; mpox-N: 8.9%) and one-time sexual partners (mpox-P: 46.1%; mpox-N: 31.7%). Multivariable logistic regressions showed that reporting stranger/client ties (adjusted OR (aOR)=10.3, 95% CI 1.39 to 76.6) with alters, being vaccinated for mpox (aOR=0.07, 95% CI 0.02 to 0.24) and tie strength heterogeneity (aOR=0.01, 95% CI 0.00 to 0.42) were associated with mpox infection.Conclusions: Our findings highlight the role of demographic, epidemiological and sexual network characteristics in the transmission of mpox virus during the outbreak in Spain. These findings have important implications for future prevention efforts.